Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-03-02 Tax Withholding | 2023-03-03 4:36 pm | N/A N/A | Entrada Therapeutics Inc. | TRDA | Sethuraman Natarajan Chief Scientific Officer | 1,058 | $11.6 | 232,486 (Direct) | View |
| 2023-03-01 Option Award | 2023-03-03 4:36 pm | N/A 2033-03-01 | Entrada Therapeutics Inc. | TRDA | Sethuraman Natarajan Chief Scientific Officer | 71,400 | $0 | 232,486 (Direct) | View |
| 2022-09-01 Option Award | 2022-09-06 4:33 pm | N/A N/A | Entrada Therapeutics Inc. | TRDA | Sethuraman Natarajan Chief Scientific Officer | 5,794 | $0 | 162,144 (Direct) | View |
| 2022-07-01 Option Award | 2022-07-06 4:16 pm | N/A 2032-07-01 | Entrada Therapeutics Inc. | TRDA | Sethuraman Natarajan Chief Scientific Officer | 34,763 | $0 | 34,763 (Direct) | View |
| 2022-03-01 Option Award | 2022-03-03 4:10 pm | N/A 2032-03-01 | Entrada Therapeutics Inc. | TRDA | Sethuraman Natarajan Chief Scientific Officer | 81,113 | $0 | 225,875 (Direct) | View |
| 2021-10-28 Option Award | 2021-11-01 7:02 pm | N/A 2031-10-28 | Entrada Therapeutics Inc. | TRDA | Sethuraman Natarajan Chief Scientific Officer | 243,639 | $0 | 243,639 (Direct) | View |
Ownership | 2021-10-28 9:01 pm | N/A N/A | Entrada Therapeutics Inc. | TRDA | Sethuraman Natarajan Chief Scientific Officer | 0 | $0 | 323,881 (Direct) | View |